Peptide procurement resources

Cosmetic peptide identity: INCI names, CAS references and blends

A cosmetic peptide trade name can describe a supplied blend. Match INCI nomenclature, chemical identity and declared composition before comparing ingredients.

Hytanbio Editorial TeamPublished 5 minute read

Unbranded cosmetic ingredient jar, clear carrier bottle and ceramic powder dish

For cosmetic peptide procurement, identify both the peptide and the material actually being supplied. A trade name may refer to a powder, a salt form or a commercial blend containing a carrier. Use the supplier’s INCI declaration, verified chemical references and composition statement together before treating two offers as equivalent.

INCI, CAS and trade names have different jobs

The Personal Care Products Council describes INCI names as standardized names for identifying cosmetic ingredients. CAS describes a CAS Registry Number as an identifier for a specific chemical substance. These systems help resolve names, but they do not replace a supplier’s statement of what is in a particular commercial raw material. Source: PCPC’s INCI overview; source: CAS REGISTRY.

Identity information for a cosmetic peptide enquiry
Reference Question for the supplier
Trade name Which supplier product and specification revision does this name identify?
INCI declaration What ingredient names are declared for the supplied material?
CAS reference Which component and chemical form does each number identify?
Composition statement Is the product a single material or a blend, and what component information is available?
Assay or concentration What is measured, in which units, and on what basis?
Lot specification Which acceptance criteria apply to the commercial material being offered?

Keep the supplied form visible

Copying a CAS reference from a peptide’s name into every related product record can create ambiguity. Ask whether it describes the peptide itself, a specified form or one component of a blend. If the supplier cannot resolve a mismatch, retain the uncertainty in the enquiry rather than choosing the most familiar number from a search result.

Request the full commercial ingredient declaration

A buyer comparing a powder with a carrier-based ingredient needs enough composition information to understand what each quotation covers. Ask which components are intentionally present and how the peptide concentration is reported. Keep the units intact. A value stated on the whole supplied blend is different from a value stated on a dry-material basis.

PCPC’s nomenclature conventions address compounded mixtures by reference to their components. Use the supplier’s current ingredient declaration as the starting document and have the relevant reviewer assess its suitability for the destination market. Do not create an INCI declaration by combining names found on unrelated product pages. Source: PCPC nomenclature conventions, mixture naming.

Separate identity confirmation from a performance claim

Matching an ingredient name does not demonstrate that two commercial blends perform identically. Their declared composition, concentration basis and specification may differ. Record the precise equivalence question you need the supplier to address. Any proposed claim for a finished cosmetic needs its own supporting evidence and market review.

Read database records within their stated scope

The European Commission states that CosIng is an information database and that an INCI name appearing there does not mean an ingredient is approved for use. PCPC also separates INCI assignment from safety or regulatory approval. A database match therefore belongs in the identity file; it should not be turned into an approval statement on a quotation or label. Source: European Commission, CosIng; source: PCPC, what INCI is not.

For a destination-market assessment, give the responsible reviewer the complete supplied-material declaration and intended cosmetic application. A search by one peptide name may leave other blend components outside the review. The purchasing file should identify who resolves that gap before label or specification approval.

Reconcile the documents before issuing the purchase order

  1. Match the quotation’s product code to the supplier specification.
  2. Compare the ingredient declaration with the stated single-material or blend description.
  3. Check which component each CAS reference identifies.
  4. Resolve conflicting units or concentration bases in writing.
  5. Confirm how composition or identity changes will be notified.
  6. Link the approved specification revision to the allocated lot documents.

Where detailed composition is confidential, ask what can be disclosed under the available document process and what your reviewer needs to close the assessment. A refusal to disclose a field should remain a visible limitation in the project record. It should not be replaced by an assumed concentration or ingredient list.

Browse the cosmetic peptide ingredient category and use the enquiry form to specify whether you need a powder or a defined commercial blend. Research-only catalog materials retain their stated use restriction and should not be silently substituted into a cosmetic ingredient brief.

Frequently asked questions

Does a CAS number describe an entire cosmetic peptide blend?

Confirm what the specific reference identifies. A number associated with one component should not be treated as a complete composition statement for a commercial blend.

Does an INCI name mean the ingredient is approved for cosmetics?

No. PCPC and the European Commission distinguish ingredient nomenclature from approval and suitability. The supplied material and intended market require their own review.

Can two products with the same peptide name be purchased interchangeably?

Compare supplied form, composition, concentration basis and specification first. A shared name does not resolve differences in commercial ingredients.

What should an enquiry say when the required blend composition is not yet fixed?

State the identity question, intended cosmetic application and documents needed for review. Ask the supplier to propose a defined material with an explicit composition and specification.

References

  1. PCPC: INCI overview and limitations
  2. CAS: CAS REGISTRY identifiers
  3. European Commission: CosIng information and disclaimer
  4. PCPC: nomenclature conventions, February 2022

Source pages checked on 31 October 2026. Procurement examples are editorial illustrations; they are not batch results or company certification claims.

Editorial scope: B2B material identity, document review and procurement. Research-only materials retain their stated restrictions. Product specifications and available documents require confirmation for the proposed lot and project.

SEND A SPEC-FIRST BULK ENQUIRY

Start with identity, quantity,
packaging and documents.

Send bulk RFQ ↗
WhatsApp